Search - tctmd.com

Displaying 281 - 300 of 407

Sort: Relevancy | Date

News Daily News

Infection Risk No Higher With Recycled Pacemakers, Defibrillators

L.A. McKeown

May 07, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Opinion CV Team Dispatch

May 2020 News Roundup

L.A. McKeown

May 06, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

L.A. McKeown

May 05, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

News Daily News

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Caitlin E. Cox

April 30, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

SMASH: Population-Based Sodium Reduction Sees Success in China

L.A. McKeown

April 28, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

Caitlin E. Cox

April 24, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Features

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Shelley Wood

April 21, 2020

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

L.A. McKeown

April 21, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

Advertisement

Infection Risk No Higher With Recycled Pacemakers, Defibrillators

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

May 2020 News Roundup

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

TCTMD’s Top 10 Most Popular Stories for April 2020

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

SMASH: Population-Based Sodium Reduction Sees Success in China

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content